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Macroautophagy is a bulk degradation process that mediates the clearance of long-lived proteins, aggregates, or even whole
organelles. This process includes the formation of autophagosomes, double-membrane structures responsible for delivering cargo
to lysosomes for degradation. Currently, other alternative autophagy pathways have been described, which are independent of
macroautophagic key players like Atg5 and Beclin 1 or the lipidation of LC3. In this review, we highlight recent insights in
indentifying and understanding the molecular mechanism responsible for alternative autophagic pathways.
1.Introduction
Autophagy, which is highly conserved from yeast to human,
is a cellular degradation pathway that delivers cytoplasmic
substrates to lysosomes for subsequent degradation. In
contrast to the Ubiquitin-Proteasome System (UPS), which
directly degrades monomeric proteins in the cytoplasm
or nucleus, autophagy targets a wide spectrum of sub-
strates including long-lived proteins, protein aggregates, and
organelles towards lysosomes for subsequent degradation. In
mammalian cells, autophagy occurs under basal conditions
but can be stimulated by various stress conditions including
starvation, hypoxia, and treatment with apoptosis-inducing
compounds like rapamycin. In addition to its role in
maintaining cellular homeostasis, autophagy is implicated in
a wide range of physiological and pathological conditions,
including early embryological development, clearance of
pathogens, tumor suppression, and antigen processing and
presentation [1]. In order to target cytoplasmic proteins to
the lysosomes, several autophagic pathways exist, including
microautophagy, chaperone-mediated autophagy (CMA),
and macroautophagy. While micro- and macroautophagy
can occur both in eukaryotes, plants, and fungi, CMA
has only been observed in mammals. Microautophagy is
the direct engulfment of cytoplasm or whole organelles by
invagination or protrusion of arm-like structures of the
lysosomalmembrane.Here,thesequestrationofcytoplasmic
cargo occurs directly at the vacuole surface [2–5]. The
secondtypeofautophagyisCMA,whichselectivelydegrades
speciﬁc cytosolic proteins containing a pentapeptide motif
(KFERQ) that is recognized by the heat shock cognate
protein 70 (Hsc70) [6, 7]. The chaperone-substrate complex
subsequently binds the lysosome through interaction with
thereceptorLamp-2aonthelysosomalmembrane[8].Upon
delivery by Hsc70, the substrate protein is unfolded before
crossing the lysosomalmembrane andlysosomalHsc70pulls
the substrate into the lysosomal matrix where it is degraded
by proteases [9]. The last but main type of autophagy is
macroautophagy. Here, double-membrane vesicles, termed
autophagosomes, are formed and sequester portions of
cytosolic content or intact organelles (such as mitochondria)
[10]. These autophagosomes are subsequently transported
in a dynein-dependent manner along microtubules and
fuse with endosomes or directly with lysosomes to form
autolysosomes, resulting in breakdown of their contents
by hydrolytic enzymes [11]. Macroautophagy is the major
cellular pathway to recycle cell components including long-
lived proteins and organelles, thereby providing nutrients
for the eukaryotic cell, and it is activated under nutrient
starvation. Additionally, macroautophagy is essential for
development, cell survival, and tissue-speciﬁc processes
[12, 13]. The initiation of autophagosome formation starts
with the phagophore (autophagosome precursor), and re-
cent studies indicate that the source of the membrane is2 International Journal of Cell Biology
the endoplasmatic reticulum (ER) [14, 15]. However, alter-
native sources for the autophagosomal membrane have been
proposed, including the Golgi apparatus, and therefore the
origin of the phagophore membrane still remains unresolved
[16, 17].
2. Macroautophagy
Macroautophagy is a multistep process controlled by pro-
teins termed autophagy-related (Atg) proteins [18]. The
formation of the phagophore requires the class-III-phos-
phatidylinositol 3-kinase (PI3K) Vps34 that forms a com-
plex with Beclin 1 (the mammalian orthologue of yeast
Atg6). Inhibitors of Vps34 such as methyladenine (3-MA)
or wortmannin can be used to inhibit macroautophagy
since they prevent autophagosome nucleation [19–22]. The
elongation of the autophagosomal membrane is dependent
on two ubiquitin-like conjugation systems [23]. Atg5-Atg12
controls autophagy, where Atg12 is conjugated to Atg5 in a
step that requires Atg7 (ubiquitin-activating-enzyme (E1)-
like) and Atg10 (ubiquitin-conjugating-enzyme (E2)-like).
The Atg5-Atg12 conjugation depends on Vps34 activity
and is localized onto the phagophore where it dissociates
upon formation of the autophagosome. Atg5-Atg12 forms
a complex with Atg16L that modulates the next process,
the ubiquitin-like conjugation of LC3-I (mammalian ortho-
logue of Atg8). The protein LC3 is proteolytic activated
by Atg4, which cleaves the C-terminus of LC3, thereby
generating a cytosolic LC3-I, which subsequently conjugates
with phosphatidylethanolamine (PE) to form membrane-
associated LC3-II [24] .T h i sp r o c e s sr e q u i r e sA t g 7a n d
Atg3, and the Atg16L complex modulates the LC3-I lip-
idation by acting like an E3-like enzyme [25]. Although
the Atg5-Atg12 conjugation dissociates upon completion
of the autophagosome formation, LC3-II persists with the
autophagosomal membrane even after fusion with a lyso-
somes and is regarded as a key marker for autophagosomes.
Atg4 is also involved in the deconjugation reaction of
LC3-II, as Atg4 delipidates LC3-II and removes it from
the autophagosomal membrane [24, 26]. A pathway that
negatively regulates macroautophagy is controlled by mTOR
(mammalian target of rapamycin). mTOR activity is inhib-
ited under starvation conditions, which activates starvation-
induced macroautophagy. Recently, two new key regulators
of macroautophagy, named NIX and DOR, which directly
interactwiththeautophagosome-membrane-associatedpro-
tein LC3, were identiﬁed [27]. Nix, a Bcl2-related protein
localized the outer mitochondrial membrane, has a function
as an adaptor protein and recruits autophagic components
to mitochondria via its WXXL-like domain facing the
cytoplasm [28–30]. NIX is upregulated during erythroid
diﬀerentiation where a lack of mitochondria is achieved by
mitophagy [27, 31, 32]. Interestingly, NIX-deﬁcient mice
show remaining mitochondria in matured red blood cells
suggesting that NIX is a selective autophagy receptor that
mediates mitochondrial clearance, as it directly binds LC3,
but it may also target mitochondria for degradation in
an LC3-independent manner [27, 33, 34]. Intriguingly, in
the same issue of EMBO reports, another new autophagy-
related protein was reported. Mauvezin et al. identiﬁed
the nuclear cofactor of thyroid hormone receptors, termed
DOR (diabetes- and obesity-regulated gene), as a new player
of macroautophagy [35]. Stress-induced macroautophagy
by starvation or rapamycin leads to release of DOR from
the nucleus in DOR-transfected HeLa cells. This relocal-
ization was not observed in the absence of cellular stress,
indicating that cellular stress is essential to trigger DOR
recruitment to the cytoplasm. DOR is associated with early
autophagosomes via interaction with LC3 and GATE16 but
does not colocalize with autolysosomes suggesting that DOR
has a regulatory role in recruiting substrates for autophagic
clearance. In addition, DOR-transfected HeLa cells show
increased turnover of proteins and elevated numbers of
autophagosomes compared to untreated cells. It has yet to be
discovered which role DOR is playing, as it may be involved
in targeting proteins to autophagy or in the formation and
nucleation of the autophagosome. Whether DOR activation
aﬀectsautophagy-inducedalterationsincellsurvivalremains
to be established.
Macroautophagy was originally described to target intra-
cellular organelles such as mitochondria and big protein
complexes, but over the years it became clear that also most
long-lived proteins are degraded via autophagic pathways. In
contrast, the other main degradation machinery in the cell,
the UPS, degrades mainly soluble short-lived and misfolded
proteins that are targeted to the proteasome following ubiq-
uitination (using a series of E1-E2-E3 enzymes to speciﬁcally
target proteins for destruction). The proteasome is present
in both the cytoplasm and the nucleus and can unfold and
degrade single proteins into small peptide fragments that are
subsequently recycled by peptidases. Interestingly, impair-
ment of the proteasome leads to an increase in macroau-
tophagy, indicating that macroautophagy can target accu-
mulating ubiquitinated proteasomal clients when required
[36–39]. In contrast, impairment of macroautophagy does
not lead to increased proteasome activity. Inhibition of
macroautophagy does not aﬀect the catalytic activity of the
proteasome but results in the accumulation of the macroau-
tophagy cargo receptor p62 (also termed SQSTM1) which
competes with the proteasome for ubiquitinated substrates.
Indeed, silencing of p62 increases the amount of UPS clients,
whereas overexpression of p62 inhibits degradation of the
proteasomal substrates p53 and UbG76V-GFP [40, 41]. As
p62 links ubiquitinated proteins via its ubiquitin-associated
(UBA) domain to the autophagic protein LC3-II and is itself
degraded in the process, inhibition of macroautophagy leads
to p62 accumulation which will compete and frustrate other
ubiquitin-binding proteins that participate in proteasome-
mediated degradation.
3. AlternativeAutophagic Pathways
Failure of the UPS or autophagic pathways to eﬃciently clear
proteins leads to the accumulation and subsequent aggrega-
tion of these proteins, which is a hallmark of various neu-
rodegenerative disorders including polyglutamine (polyQ)International Journal of Cell Biology 3
disorders such as Huntington’s disease. Here, fragments
of the disease-related protein containing the polyQ tract
initiate aggregation and toxicity, which can be mimicked
by expressing the expanded polyQ sequence as a peptide
[42]. Apparently, not all peptides are eﬃciently degraded by
peptidases, which led to our recently published study where
we examined potential alternative degradation machineries
when peptidases would fail in degrading protein fragments
[43]. In this study, we introduced peptidase-resistant pep-
tides into living cells and observed a perinuclear accumula-
tion of these peptides in time. Surprisingly, these structures
did not represent aggregates or inclusion bodies as observed
previously for aggregation-prone protein fragments, as no
UPS components or chaperones were recruited. Although
initially present in the nucleus and cytoplasm, the peptides
were eﬃciently targeted to lysosomes within a few hours
upon introduction into cells, and subsequently degraded.
Our results indicate, therefore, that similar to the described
increase in autophagy upon proteasome impairment, a
backup mechanism exists for small protein fragments that
show peptidase resistance. Intriguingly, this mechanism
was very eﬃcient for peptides of the average size of
proteasomal products (6–9 amino acids), but far less for
extended peptides over 25–30 amino acids which remained
cytoplasmic for prolonged periods [43]. Similar to expanded
polyQ peptides of disease-related lengths, these expanded
peptidase-resistant peptides were more resistant to clearance
by lysosomes suggesting that this pathway is particularly
eﬃcient for small peptides generated by the proteasome.
It is tempting to speculate that this mechanism evolved
as a backup to peptidases in the clearance of proteasome-
derived peptides and emphasizes the need to identify the
involved proteins. Using correlative microscopy, we mainly
observed double-membrane vesicles that contained peptides
and that colocalized with LC3. The colocalization increased
when we used Baﬁlomycin A1 to impair maturation into
autolysosomes. In contrast, we could prevent colocalization
of LC3 with the macroautophagy inhibitor 3-MA, suggesting
that the macroautophagic pathway took over the clearance of
these peptides. Unexpectedly, inhibition of macroautophagy
by inhibitors such as 3-MA or knockdown of Atg5 prevented
recruitment of LC3 but did not aﬀect the traﬃcking of these
peptides into lysosomes or their subsequent degradation.
Apparently, LC3 was recruited during the traﬃcking of
peptides towards lysosomes yet was not essential. Similar
to the knockdown of the various LC3 isoforms (LC3A-C),
knockdown of the Atg8-related GABARAP proteins, that can
interact with autophagosomes, did not aﬀect the targeting
of peptides towards lysosomes [44, 45]. As knockdown of
Atg5 or WIPI-1 did not aﬀect the traﬃcking and subsequent
degradation of peptides in lysosomes, we concluded that
these peptides entered lysosomes via a pathway diﬀerent
from macroautophagy. CMA is also unlikely to contribute to
this pathway as the peptides lack a CMA motif and peptides
composed of D-amino acids, which are unable to bind
chaperones like Hsc70, were also traﬃcking via this pathway.
Finally, we also examined endosomal microautophagy, a
process that delivers soluble cytosolic material to vesicles of
late endosomes or multivesicular bodies (MVBs) [46, 47].
Althoughaccumulatedpeptidescolocalizedwithinternalized
MHC class II molecules which may lead to so-called cross-
presentation to the immune system (unpublished observa-
tion), knockdown of the sorting complexes required for
transport (ESCRTs) I and III showed no eﬀect on peptide
accumulation in lysosomes. As no recruitment of ESCRT
regulators towards accumulated peptides was observed, this
indicates that the endosomal microautophagy pathway is not
involved in the traﬃcking and clearance of the peptidase-
resistant peptides.
The accumulation and subsequent lysosomal degrada-
tion of cytoplasmic proteins independent of known auto-
phagy pathways have been previously observed in several
studies (as described below), although in each case diﬀer-
ences in sensitivity to autophagy inhibitors and the involve-
ment of various Atg proteins were reported. Interestingly,
in a study using Green Fluorescent Protein (GFP) like
ﬂuorophores, a pathway reminiscent of that we observed for
the peptidase-resistant peptides was observed [40]. Various
GFP-like ﬂuorophores have been shown to form dimers,
tetramers, or even larger complexes. Upon expression, these
ﬂuorescent proteins formed cytoplasmic ﬂuorescent puncta
that resembled lysosomes, similar as observed for the pep-
tidase-resistant peptides [48]. However, the accumulating
ﬂuorophore proteins including monomeric RFP1 (mRFP1)
showed resistance to lysosomal degradation and retain ﬂu-
orescence, in contrast to the peptides. Traﬃcking of the
GFP-like proteins and the peptidase-resistant peptides was
not aﬀected in Atg5-deﬁcient mouse embryonic ﬁbroblasts,
suggestingthattheymaybetargetedtolysosomesbyasimilar
pathway (although no other macroautophagy markers were
examined for the ﬂuorescent proteins). So is the constitutive
macroautophagy-independent targeting of cytoplasmic pro-
teins and peptides to autolysosomes restricted to introduced
peptides and GFP-like ﬂuorophores?
At least two alternative autophagy pathways have been
described: an Atg5/Atg7-independent pathway and the so-
called noncanonical autophagy pathway, which is inde-
pendent of Beclin 1 (Table 1). The Atg5/Atg7-independent
autophagic pathway was recently discovered in mouse
embryonic ﬁbroblasts (MEF) lacking Atg5 and Atg7 that
were treated with the cytotoxic stressor etoposide, which
caused an equivalent appearance of autophagic vacuoles
when compared to wild-type cells [49]. Moreover, auto-
phagic vacuoles were also found in starved Atg5-/- cells. The
Atg5/Atg7-independent form of autophagy does not involve
the lipidated conjugate LC3-II, which is membrane associ-
ated. Interestingly, equivalent numbers of LC3-positive and
LC3-negative autophagosomes were observed in etoposide-
treated wild-type cells, suggesting that conventional and
alternative autophagic pathway occur at the same time.
The proteins Atg5, Atg7, and LC3, which are important in
the ubiquitin-like conjugation system for the autophago-
some elongation, are not involved in this alternative form
of autophagy. However, silencing of Beclin 1 and Vps34
decreased the amount of autophagosomes, indicating that
the PI3K complex, which acts upstream of initiation of
autophagosome formation, is still required in etoposide- or
starvation-induced autophagy in Atg5-/- cells. Accordingly,4 International Journal of Cell Biology
Table 1: Types of alternative macroautophagic pathways.
Alternative
macroautophagic
pathways
Macroautopagic
molecules involved
Macroautopagic molecules
not involved Induction Cell type Reference
Beclin 1-independent
Atg5
Atg7
Ulk1/2
LC3
Beclin 1
(Vps34)
Resveratrol MCF-7 (breast cancer cells) [50]
Staurosporine
Etoposide
MK801
primary cortical neurons [51]
H2O2
RAW 264.7 (macrophage
cells)
[52]
MPP+ SH-SY5Y (neuroblastoma
cells)
[53]
primary dopaminergic
neurons
As2O3 ovarian cells [55]
Atg5/Atg7-
independent
Beclin 1
Vps34
Ulk1
Fip200
Atg5
Atg7
Atg9
Atg12
Atg16
LC3
Etoposide
Staurosporine
Starvation
Atg5-/- MEF
Atg7-/- MEF
wt MEF
[49]
Degradation of
peptidase-resistant
peptides
LC3 (but not
essential)
Atg5
WIPI-1
p62
Tsg101
Vps24
Resistance against
cytoplasmic
peptidases
HeLa
Atg5-/- MEF
wt MEF
[43]
protein degradation via this pathway was inhibited by the
PI3Kinhibitor 3-MA.Furthermore,silencing of components
of the Ulk1 complex, a mammalian serine/threonine protein
kinase that plays a key role in the initial stages of autophagy,
decreased autophagic vacuoles, suggesting that the Ulk1
complex is needed for Atg5/Atg7-independent autophagy
[49].
Apoptosis-induced stress, for example, by staurosporine,
resveratrol, or H2O2 can also induce the so-called non-
canonical autophagy pathway, where autophagosomes can
be formed independent of Beclin 1 or Vps34 and with
an insensitivity to 3-MA [50–52]. However, this speciﬁc
pathway still requires Atg7-activity for LC3-I lipidation
and is, therefore, diﬀerent from the Atg5/Atg7-independent
pathway described above [49]. Furthermore, Scarlatti et al.
have shown that resveratrol inhibits the mTOR activation by
a direct inhibitory eﬀect on the upstream class 1A PI3K [50].
Similarly, a Beclin 1-independent pathway has been reported
in neuronal cells treated with the neurotoxin 1-methyl-4-
phenylpyridinium(MPP+)[53]andinothercellularsystems
in response to various drugs [54, 55]. These studies have
shown that several agents stimulate autophagic cell death
through Beclin 1 in canonical autophagy pathways [56].
Recently, evidence emerged that autophagy and cell death
are induced independent of Beclin 1 and Vps34. In breast
cancer cells, resveratrol induces autophagic cell death in a
Beclin1-independentmanner[50].SilencingofAtg7impairs
the cellular death elicited by resveratrol. In dopaminergic
neuronal cells, the neutotoxin MPP+ induces Beclin 1-
independent autophagy and cell death [53]. As most studies
on the noncanonical pathway used compounds to induce
cell death, it is tempting to link the noncanonical autophagy
pathway to a death execution mechanism or cell survival.
However, it has also been suggested that the independency
of the noncanonical autophagy pathway may provide an
adaptation to loss of Beclin 1, for example, in various tumors
where Beclin 1 is deleted, in immune cell development, and
may even be an evolutionary way to circumvent inhibition
of Beclin 1 by various viruses in order to prevent autophagy
[57–59].
None of these alternative autophagy pathways seem to
correspond to the traﬃcking we observed for the peptidase-
resistant peptides, as the Atg5/Atg7-independent pathway
is still 3-MA sensitive (in contrast to the peptide targeted
to lysosomes), while the noncanonical pathway (Beclin 1-
independent) is 3-MA insensitive but still depends on LC3.
Thus, lysosomal degradation of peptidase-resistant peptides
and proteins, as we and others have demonstrated [35, 41–
45], deﬁnes a novel authophagy route independent of known
regulators of the constitutive macroautophagic pathway like
Beclin 1, Atg5 or LC3. A better understanding of the
role of these alternative autophagic pathways and their
molecular regulators raise to two crucial questions: (1) What
is the origin of the autophagic membrane in the diﬀerent
autophagicroutes,and(2)Whichstimulitriggerthediﬀerent
autophagic pathways?
In mammalian macroautophagy, various sources for the
origin of the autophagosome membrane have been proposed
including the ER, the Golgi complex, the plasma membrane,
and the mitochondria [17, 60–66]. Alternatively, de novo
synthesis of a nucleating structure, the phagophore, is
proposed to elongate by the addition of lipids via the integralInternational Journal of Cell Biology 5
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Figure 1: Alternative macroautophagic pathways lead to lysosomal degradation. At least four autophagic pathways can be distinguished that
all show double-membrane autophagic structures and end in lysosomal degradation of cytoplasmic cargo. Conventional macroautophagy
is hallmarked by the recruitment of lipidated LC3 to autophagosomal membranes that may origin from the endoplasmatic reticulum (ER).
This process is dependent on Atg5 and Beclin 1 and can be inhibited by 3-methyladenine (3-MA). In contrast, the observed Atg5/Atg7-
independent autophagy pathway forms Rab9-positive double-membrane vesicles derived from the trans-Golgi network and late endosomes
(LE), and while it can be inhibited by 3-MA and is dependent on Beclin 1, the process is independent of Atg5 and LC3. Almost similar, the
degradation of accumulated peptidase-resistant peptides is independent of Atg5 and LC3 and is also insensitive to 3-MA treatment. Finally,
the noncanonical autophagy pathway induced by diﬀerent stress factors is dependent on Atg5 and LC3 and independent of Beclin 1 but
cannot be impaired by 3-MA.
membrane protein Atg9 [67–70]. Atg9 seems to be a key reg-
ulator in regulating the formation and expansion of nascent
autophagosomes. Unfortunately, the identity of proteins that
partition to the autophagosomal membrane remains largely
unknown. Therefore, attempting to determine the origin
of the autophagosomal membrane based on the associated
proteins remains a challenge [71]. Alternatively, others at-
tempted to determine the source of the autophagosomal
membrane by inspecting its thickness and lipid composition
[15]. Several studies reported that the autophagosomal
membrane can be classiﬁed as of a thin type (6–8nm), sim-
ilar to membranes of the ER and mitochondria [60, 72–75].
Furthermore, lipid structures enriched in PI3P (known as
omegasomes) were formed in the vicinity of ER membranes
after amino acid starvation, suggesting that these omega-
somes originate from the ER [76–79]. As the omegasomes
carry autophagosomal proteins like Atg5 and LC3, they may
represent the source of isolated membranes required for
autophagosome expansion. In contrast, in the Atg5/Atg7-
independent autophagic pathway, autophagosomes with
membranes of the thick type (9-10nm) were observed, sim-
ilar to membranes of lysosomes and the trans-Golgi network
[49]. Intriguingly, unlike the conventional pathway the alter-
native Atg5/Atg7-independent form of autophagy is blocked
by brefeldin A, indicating that autophagosomes are derived
from the Golgi-apparatus. Etoposide-induced Atg5/Atg7-
independent autophagy is accompanied by colocalization
of markers of the trans-Golgi and late endosomes (such
as the mannose 6-phosphate receptor, TGN38, and Rab9)
with Lamp-2-positive autolysosomes, further pointing to the
requirement of the trans-Golgi or late endosomes in this
alternative form of autophagy. Indeed, silencing of Rab9 or
expression of a Rab9 dominant negative mutant established
an essential role for Rab9 in membrane expansion from
isolated membranes and led to an accumulation of isolated
membranes after silencing of Rab9 but not upon inhibition
of Ulk1 or Beclin 1. Since the Atg5/Atg7-independent type
of alternative autophagy is activated by starvation and the
stress-inducingreagentetoposide,butnotbyrapamycin,this
suggests that a speciﬁc stimulus for induction of autophagy
activates nonconventional macroautophagy with diﬀerent
lipid structures compared to conventional macroautophagy.
To the best of our knowledge, there is no clear data on
the source of membrane for the Beclin 1-independent non-
canonical autophagy pathway.
So far, several sources have been proposed to provide the
putative moiety of autophagosomal membranes. However,
autophagosomal membranes could derive from multiple
membrane sources and the origin of lipids may vary depen-
dent on the cell type, the stimulus that triggers the degra-
dation, and the type of cargo for autophagic destruction
(proteins, aggregates or even whole organelles). As shown in
Figure 1,therearenowatleastthreealternativepathwaysthat
target cytosolic content to lysosomes, which can be discrim-
inated by their dependence on Atg5 and 3-MA (Figure 1).
The identiﬁcation of key players and the origin of membrane6 International Journal of Cell Biology
structures involved in alternative autophagic pathways will
beimportantfortheunderstandingofmolecularmechanism
regulating these various types of autophagy.
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